MENLO PARK, Calif. — An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has reportedly created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors an A.I. outbreak in Turkey in 2005.
These antibody libraries could prevent a pandemic and provide treatment to infected people, as well as potentially pointing the way toward the development of a universal flu vaccine, according to the company. The expanded treatment and containment options could help healthcare officials combat an A.I. outbreak.
Read the full MeatPoultry.com story here.
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer
